A Phase 3, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, 2 Arm, Parallel Group Study Comparing the Safety and Efficacy of Tazarotene and Tazarotene Vehicle Lotion in the Treatment of Acne Vulgaris
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 05 Apr 2018
At a glance
- Drugs Tazarotene
- Indications Acne vulgaris
- Focus Registrational; Therapeutic Use
- Sponsors Ortho Dermatologics; Valeant Pharmaceuticals International
- 29 Mar 2018 Planned primary completion date changed from 30 Apr 2018 to 6 Jun 2018.
- 29 Mar 2018 Status changed from recruiting to active, no longer recruiting.
- 11 Aug 2017 Status changed from not yet recruiting to recruiting.